Chemed (CHE) Receivables - Other (2010 - 2025)

Chemed has reported Receivables - Other for 15 years, with the latest figure at $8.6 million in Q4 2025.

• For the quarter ending Q4 2025, Receivables - Other fell 1.58% year-over-year to $8.6 million; the trailing twelve-month figure through Dec 2025 stood at $8.6 million (down 1.58% YoY), and the FY2025 full-year result was $8.6 million, down 1.58% from the prior year.
• Receivables - Other for Q4 2025 stood at $8.6 million, up from $8.1 million in the prior quarter.
• The five-year high for Receivables - Other was $8.8 million in Q4 2024, with the low at $1.5 million in Q2 2025.
• Average Receivables - Other over 5 years is $3.1 million, with a median of $1.8 million recorded in 2024.
• Year-over-year, Receivables - Other jumped 428.5% in 2024 and dropped 24.48% in 2025.
• Tracing CHE's Receivables - Other over 5 years: stood at $1.9 million in 2021, then fell by 3.59% to $1.8 million in 2022, then fell by 8.93% to $1.7 million in 2023, then jumped by 428.5% to $8.8 million in 2024, then decreased by 1.58% to $8.6 million in 2025.
• The last three Receivables - Other figures came in at $8.6 million (Q4 2025), $8.1 million (Q3 2025), and $1.5 million (Q2 2025), per Business Quant data.

Peer Comparison